Search results
House GOP approves mammoth annual defense bill with culture war amendments
The Hill· 12 hours agoThe House on Friday approved its version of the annual defense policy bill that includes a number of...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 5 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
LA ends controversial vaccine mandate for city employees
FOX 11 News Los Angeles· 4 days agoThe City of Los Angeles has ended its COVID-19 vaccine mandate for municipal employees, more than a...
Los Angeles City Council ends order that city employees get COVID-19 vaccine
Los Angeles Daily News· 3 days agoMore than a year after the Los Angeles City Council lifted the city’s declaration of emergency...
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine | Fox 11 Tri Cities Fox 41...
FOX 11/41 Yakima· 5 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 4 days agoThe results raise hopes the new vaccine could be approved by regulators for the 2025 or 2026 flu...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 4 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory ...
Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season
FierceBiotech· 5 days agoModerna’s combo flu and COVID-19 vaccine zipped through a late-stage trial this winter, and the...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 4 days agoThe ongoing clinical trial pits this new combination shot, called mRNA-1083, against several licensed vaccines that protect against either COVID-
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 7 days agoAlthough Moderna (NASDAQ: MRNA) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Its success in...